BCAL Diagnostics (ASX:BDX) Payments of Debt: A$-1.53 Mil (TTM As of Dec. 2025)


What is BCAL Diagnostics Payments of Debt?

BCAL Diagnostics ASX:BDX +1.39% Payments of Debt is A$-1.53 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

BCAL Diagnostics's Payments of Debt for the six months ended in Dec. 2025 was A$-1.44 Mil.

BCAL Diagnostics's Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2025 was A$-1.53 Mil.

BCAL Diagnostics Payments of Debt Related Terms

BCAL Diagnostics Payments of Debt Historical Data

* Premium members only.

The historical data trend for BCAL Diagnostics's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BCAL Diagnostics Payments of Debt Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Payments of Debt
0.00 0.00 -0.26 -0.22

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.16 -0.10 -0.12 -0.10 -1.44

BCAL Diagnostics Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-1.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of A$-1.53 Mil mean?
BCAL Diagnostics (ASX:BDX) has a Payments of Debt of A$-1.53 Mil as of Dec. 2025. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on BCAL Diagnostics and its competitors.
Is BCAL Diagnostics' Payments of Debt too high?
BCAL Diagnostics' current Payments of Debt is A$-1.53 Mil.
How does BCAL Diagnostics' Payments of Debt compare to TMO and DHR?
BCAL Diagnostics' Payments of Debt of A$-1.53 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Medical Diagnostics & Research company?
A good Payments of Debt depends on the Medical Diagnostics & Research industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on BCAL Diagnostics and its competitors. BCAL Diagnostics's current Payments of Debt is A$-1.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BCAL Diagnostics stock overvalued right now?
BCAL Diagnostics (ASX:BDX) has a current Payments of Debt of A$-1.53 Mil. The current Payments of Debt is A$-1.53 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For BCAL Diagnostics (ASX:BDX), the current Payments of Debt is A$-1.53 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BCAL Diagnostics Business Description

Address 50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer that is safe, cost-effective, accurate, and available to all women regardless of age, race, and geographic location.